Argen X SE Operating Income

As of the most recent data (June 2026), ARGX shows a operating income of $1.5B. That compares with $-130M in the prior-year period — up 1207.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARGX's operating income is now $1.5B (was $-130M) — a 1207.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Argen X SE is outperforming or lagging.

Tracking ARGX's operating income over time shows whether Argen X SE is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5B That compares with $-130M in the prior-year period — up 1207.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Argen X SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $1.5B) with ownership activity and broader fundamentals.

Argen X SE's operating income is $1.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.